OTLK icon

Outlook Therapeutics

18 hedge funds and large institutions have $27M invested in Outlook Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 1 closing their positions.

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
5
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$9.64M 2,268,585 +199,617 +10%
PA
2
Perceptive Advisors
New York
$5.31M 1,248,990 -63,773 -5%
CAM
3
Cormorant Asset Management
Massachusetts
$4.37M 1,027,216
ACA
4
Avoro Capital Advisors
New York
$1.92M 450,872 -15,795 -3%
Marshall Wace
5
Marshall Wace
United Kingdom
$1.06M 250,200
ACP
6
Acuta Capital Partners
California
$1.04M 245,391 +2,000 +0.8%
SFM
7
Sphera Funds Management
Israel
$850K 200,000 -59,000 -23%
PC
8
PointState Capital
New York
$850K 200,000
Goldman Sachs
9
Goldman Sachs
New York
$555K 130,699 +130,699 New
JG
10
Jefferies Group
New York
$418K 98,300 -60,395 -38%
Vanguard Group
11
Vanguard Group
Pennsylvania
$396K 93,115 +93,115 New
Millennium Management
12
Millennium Management
New York
$359K 84,500 -3,650 -4%
Bank of America
13
Bank of America
North Carolina
$83K 19,521 +19,521 New
Morgan Stanley
14
Morgan Stanley
New York
$76K 17,900 +7,900 +79%
VKH
15
Virtu KCG Holdings
New York
$43K 10,017 +10,017 New
UBS Group
16
UBS Group
Switzerland
$8K 2,036 +536 +36%
TRCT
17
Tower Research Capital (TRC)
New York
$3K 700 +100 +17%
Hudson Bay Capital Management
18
Hudson Bay Capital Management
Connecticut
-62,500 Closed
Wells Fargo
19
Wells Fargo
California
$0 100
MIM
20
Monashee Investment Management
Massachusetts